Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has disclosed that its subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order for the Drug License of its store located at Ram Mandir Circle, Rajaji Nagar, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-01, and was received on 17.07.2025. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of approximately Rs 1.61 lakhs from this suspension. The disclosure has been made under SEBI LODR Regulation 30 read with Para A of Part A of Schedule III.
The financial impact is negligible at around Rs 1.61 lakhs, and this is a routine, single-store compliance issue with no material bearing on the company's overall operations or stock price.